Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Is The Skin Cancer Diagnostics Market Expected To Grow In Terms Of Size?
The market size for skin cancer diagnostics has seen robust growth in the previous years. Its size is projected to expand from $3.13 billion in 2024 to $3.38 billion in 2025, marking an 8.0% compound annual growth rate (CAGR). Factors contributing to this growth during the historic period include a rise in skin cancer cases, an increasing aged demographic, heightened awareness and educational campaigns, as well as government strategies aimed at early detection.
Over the coming years, the skin cancer diagnostics market is anticipated to witness substantial growth, reaching a value of $4.67 billion by 2029, indicating a compound annual growth rate (CAGR) of 8.4%. This growth during the projected period can be connected to increased awareness about sun exposure, the adaptation of personalized medicine, advancements in telemedicine and remote monitoring, and the worldwide expansion of healthcare infrastructure. Foundational trends during the forecast period encompass the incorporation of digital health platforms, the development of innovative skin cancer treatments, the application of multi-disciplinary methodologies, innovations in dermatopathology, and the enhancement of patient education and awareness.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11914&type=smp
What Market Forces Are Contributing To The Growth Of The Skin Cancer Diagnostics Market?
The skin cancer diagnostics market is anticipated to expand due to the rising incidence of melanoma, a type of skin cancer that originates from the cells that generate melanin, the pigment that gives color to skin, hair, and eyes. Diagnostics for skin cancer are critical for detecting and defining skin lesions, which allows for early detection, precise diagnosis, and successful treatment planning for skin cancer. For example, a report from the American Cancer Society Inc., a prominent voluntary health organization in the US aiming to eradicate cancer, revealed an increase in the number of men in the US with melanoma from 57,180 in 2022 to 58,120 in 2023. Additionally, data from the American Society of Clinical Oncology, a US professional organization that represents all oncology doctors, stated that in March 2023, melanoma made up about 1% of all diagnosed skin cancers in the US. Despite this, it is the primary cause of mortality from skin cancer. It is projected that melanoma will cause the death of 7,990 individuals in the US in 2023, with 5,420 being males and 2,570 females. Consequently, the escalating number of melanoma cases is propelling the growth of the skin cancer diagnostics market.
How Is The Skin Cancer Diagnostics Market Segmented Across Key Categories?
The skin cancer diagnosticsmarket covered in this report is segmented –
1) By Cancer Type: Basal Cell Carcinoma, Squamous Cell Carcinoma, Malignant Melanoma, Other Cancer Types
2) By Type: Diagnosis, Therapeutics
3) By Application: Hospital, Clinic, Laboratory, Other Applications
Subsegments:
1) By Basal Cell Carcinoma: Diagnostic imaging Techniques; Biopsy Procedures; Molecular Diagnostic Tests
2) By Squamous Cell Carcinoma: Diagnostic imaging Techniques; Biopsy Procedures; Molecular Diagnostic Tests
3) By Malignant Melanoma: Diagnostic Imaging Techniques; Biopsy Procedures; Molecular Diagnostic Tests
4) By Other Cancer Types: Non-Melanoma Skin Cancers; Dermatofibrosarcoma Protuberans; Merkel Cell Carcinoma
What Key Trends Are Driving Growth In The Skin Cancer Diagnostics Market?
Leading businesses in the skin cancer diagnostics market, are directing their efforts into product innovation, specifically tools like PRAME protein, to improve both detection and treatment methods for melanoma and other skin cancer types. PRAME, short for Preferentially Expressed Antigen in Melanoma, is a cancer/testis antigen that demonstrates potential as a melanoma diagnostic biomarker. For example, in October 2022, Roche, a global healthcare provider based in Switzerland, introduced its PRAME (EPR20330) Antibody. This particular antibody is a melanoma-related antigen that specializes in recognizing PRAME protein expression in tissue samples taken from patients who may have melanoma. It plays a crucial role in differentiating between benign and malignant lesions. If PRAME expression is detected, it implies malignancy, a vital factor for precise diagnosis and creating an effective treatment plan.
Who Are The Major Stakeholders Operating In The Skin Cancer Diagnostics Market?
Major companies operating in the skin cancer diagnostics market include Pfizer Inc., F. Hoffmann-La Roche Limited, Merck & Co., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sanofi, Eli Lilly and Company, Canon Medical Systems Corporation, Amgen Inc., GE Healthcare, Daiichi Sankyo Company Limited., National Cancer Institute, Agilent Technologies Inc., bioMerieux SA, Teva Pharmaceutical Industries, Bruker Corp, Almirall, Genentech, Castle Biosciences, Sun Pharmaceutical Industries Limited., American Academy of Dermatology, Biolitec Ag, Alma Lasers, DermTech Inc., SkylineDx BV, DermLite LLC, AMLo Biosciences Limited
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/skin-cancer-diagnostics-global-market-report
How Do Regional Dynamics Influence The Skin Cancer Diagnostics Market Performance?
North America was the largest region in the skin cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the skin cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=11914&type=smp
Browse Through More Reports Similar to the Global Skin Cancer Diagnostics Market 2025, By The Business Research Company
Personal Care Shower And Bath Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/personal-care-shower-and-bath-global-market-report
Luxury Hair Care Products Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/luxury-hair-care-products-global-market-report
Natural Skin Care Products Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/natural-skin-care-products-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model